Literature DB >> 20955406

HDAC inhibitors induce cell cycle arrest, activate the apoptotic extrinsic pathway and synergize with a novel PIM inhibitor in Hodgkin lymphoma-derived cell lines.

Esperanza Martín-Sánchez, Margarita Sánchez-Beato, María Elena Rodríguez, Beatriz Sánchez-Espiridión, Cristina Gómez-Abad, James R Bischoff, Miguel A Piris, Africa García-Orad, Juan F García.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20955406     DOI： 10.1111/j.1365-2141.2010.08401.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

Review 1.  Novel agents in Hodgkin lymphoma.

Authors:  Alison J Moskowitz
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

2.  PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.

Authors:  Esperanza Martín-Sánchez; Lina Odqvist; Socorro M Rodríguez-Pinilla; Margarita Sánchez-Beato; Giovanna Roncador; Beatriz Domínguez-González; Carmen Blanco-Aparicio; Ana M García Collazo; Esther González Cantalapiedra; Joaquín Pastor Fernández; Soraya Curiel del Olmo; Helena Pisonero; Rebeca Madureira; Carmen Almaraz; Manuela Mollejo; F Javier Alves; Javier Menárguez; Fernando González-Palacios; José Luis Rodríguez-Peralto; Pablo L Ortiz-Romero; Francisco X Real; Juan F García; James R Bischoff; Miguel A Piris
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.